Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

被引：0
|
作者：
Ntanasis-Stathopoulos, Ioannis [1 ]
Katodrytou, Eirini [2 ]
Hatjiharissi, Evdoxia [3 ]
Spanoudakis, Emmanouil [4 ]
Douka, Vasiliki [5 ,6 ]
Fotiou, Despina [1 ]
Labropoulou, Vasiliki [7 ]
Dalampira, Dimitra [2 ]
Spiliopoulou, Vasiliki [1 ]
Papadopoulou, Theodosia [2 ]
Christoulas, Dimitrios [8 ]
Malandrakis, Panagiotis [1 ]
Bouchla, Anthi [9 ]
Pappa, Vasiliki [10 ]
Kastritis, Efstathios [1 ]
Terpos, Evangelos [1 ]
Dimopoulos, Meletios [1 ]
Gavriatopoulou, Maria [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[2] Theagenio Canc Hosp, Dept Hematol, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Dept Internal Med 1,Div Hematol, Thessaloniki, Greece
[4] Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece
[5] Papanikolaou Gen Hosp, Dept Hematol, Thessaloniki, Greece
[6] Papanikolaou Gen Hosp, Bone Marrow Transplantat Unit, Thessaloniki, Greece
[7] Univ Patras, Med Sch, Div Hematol, Patras, Greece
[8] 251 Gen AirForce Hosp, Dept Haematol, Athens, Greece
[9] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Hematol Div, Haidari, Greece
[10] Attikon Gen Hosp, Dept Hematol, Athens, Greece
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206900
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6988 / 6990
页数：3
相关论文
共 50 条
  • [31] Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
    Dong, Sharlene
    Banerjee, Rahul
    Khan, Adeel M.
    Wang, Mengru
    Wang, Xiaoliang
    Afghahi, Anosheh
    Afrough, Aimaz
    Janakiram, Murali
    Wang, Bo
    Cowan, Andrew J.
    Sperling, Adam S.
    Anderson Jr, Larry D.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [32] Real World Evaluation of Teclistamab: A Focus on Infections in Patients With Relapsed Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Martin, Thomas
    Wolf, Jeffrey
    Chung, Alfred
    Arora, Shagun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S536 - S537
  • [33] The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a "real-world" study: Polish Myeloma Group experience
    Charlinski, Grzegorz
    Grzasko, Norbert
    Jurczyszyn, Artur
    Janczarski, Mariusz
    Szeremet, Agnieszka
    Waszczuk-Gajda, Anna
    Bernatowicz, Pawel
    Swiderska, Alina
    Guzicka-Kazimierczak, Renata
    Lech-Maranda, Ewa
    Szczepaniak, Andrzej
    Wichary, Ryszard
    Dmoszynska, Anna
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 354 - 361
  • [34] Teclistamab for relapsed refractory multiple myeloma patients on dialysis
    Lebreton, P.
    Lachenal, F.
    Bouillie, S.
    Pica, G. M.
    Aftisse, H.
    Pascal, L.
    Montes, L.
    Macro, M.
    Johnson, N.
    Harel, S.
    Fernandez, M.
    De Renzis, B.
    Lioure, B.
    Lazareth, A.
    Javelot, M.
    Louni, C.
    Huart, A.
    Perrot, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 2077 - 2079
  • [35] Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
    Naqvi, Syed
    Shrestha, Asis
    Alzubi, Marah
    Alrawabdeh, Jawad
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Schinke, Carolina
    Al Hadidi, Samer
    EJHAEM, 2024, 5 (04): : 789 - 792
  • [36] Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providers
    Schinke, Carolina
    Dhakal, Binod
    Mazzoni, Sandra
    Shenoy, Samantha
    Scott, Sara A.
    Richards, Tiffany
    Le, Hoa H.
    DeBrosse, Amalia
    Okorozo, Peter
    McDowell, Rachel
    Patel, Saurabh
    Bunn, Jonathan
    Hawks, Kelly
    Zhang, Xinke
    Rodriguez, Cesar
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (10) : 1705 - 1711
  • [37] DURATION OF THERAPY IN US PATIENTS TREATED FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE REAL-WORLD
    Romanus, D.
    Raju, A.
    Yong, C.
    Seal, B.
    Farrelly, E.
    Noga, S.
    Jhaveri, M.
    Labotka, R.
    Blazer, M.
    Parameswaran, H.
    HAEMATOLOGICA, 2016, 101 : 538 - 539
  • [38] "Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
    Katodritou, Eirini
    Vadikolia, Chrysanthi
    Lalagianni, Chrysavgi
    Kotsopoulou, Maria
    Papageorgiou, Georgia
    Kyrtsonis, Marie-Christine
    Matsouka, Panagiota
    Giannakoulas, Nikolaos
    Kyriakou, Despoina
    Karras, Georgios
    Anagnostopoulos, Nikolaos
    Michali, Evridiki
    Briasoulis, Evangelos
    Hatzimichael, Eleftheria
    Spanoudakis, Emmanouil
    Zikos, Panagiotis
    Tsakiridou, Anastasia
    Tsionos, Konstantinos
    Anargyrou, Konstantinos
    Symeonidis, Argiris
    Maniatis, Alice
    Terpos, Evangelos
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 129 - 139
  • [39] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [40] “Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
    Eirini Katodritou
    Chrysanthi Vadikolia
    Chrysavgi Lalagianni
    Maria Kotsopoulou
    Georgia Papageorgiou
    Marie-Christine Kyrtsonis
    Panagiota Matsouka
    Nikolaos Giannakoulas
    Despoina Kyriakou
    Georgios Karras
    Nikolaos Anagnostopoulos
    Evridiki Michali
    Evangelos Briasoulis
    Eleftheria Hatzimichael
    Emmanouil Spanoudakis
    Panagiotis Zikos
    Anastasia Tsakiridou
    Konstantinos Tsionos
    Konstantinos Anargyrou
    Argiris Symeonidis
    Alice Maniatis
    Evangelos Terpos
    Annals of Hematology, 2014, 93 : 129 - 139
12345